AEON Biopharma, Inc. Total Liabilities and Equity
AEON Biopharma, Inc. (AEON) had Total Liabilities and Equity of $5.91 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-12
- 2026-06-30: Liabilities and Equity $5.91M.
- 2026-03-31: Liabilities and Equity $8.63M.
- 2025-12-31: Liabilities and Equity $5.56M.
- 2025-09-30: Liabilities and Equity $8.73M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $5.91M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $8.63M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $5.56M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $8.73M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $11.66M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $13.80M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $3.14M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $4.00M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $5.73M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $3.03M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $6.84M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $17.62M 10-Q/A · filed 2024-03-29 | |
| 2023-06-30 | $21.79M 10-Q · filed 2023-07-21 | |
| 2023-03-31 | $21.62M 10-Q · filed 2023-05-17 | |
| 2022-12-31 | $10.78M 10-K/A · filed 2024-05-14 | $279.49M 10-K · filed 2023-02-22 |
| 2022-09-30 | $277.32M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $276.51M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $276.65M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $276.95M 10-K/A · filed 2023-04-10 | |
| 2021-09-30 | $277.20M 10-Q/A · filed 2022-03-03 | |
| 2021-06-30 | $277.62M 10-Q/A · filed 2022-03-03 | |
| 2021-03-31 | $278.15M 10-Q/A · filed 2022-03-03 | |
| 2020-12-31 | $81.00K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |